Ballentine Carter
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Endocrinology, Diabetes and Metabolism top 10%
- Cancer Research
- Pharmacology
- Co-authors
- R. P. MacShalender BhasinGlenn R. CunninghamAtam B. SinghAlan W. PartinJohan SkogMichael DonovanJames M. McKiernan
- Topics
- Prostate Cancer Diagnosis and Treatment (7 papers)Prostate Cancer Treatment and Research (4 papers)Hormonal and reproductive studies (1 paper)
- Partner nations
- United States
In The Last Decade
Ballentine Carter
6 papers receiving 438 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Molecular Biology 266
- Pulmonary and Respiratory Medicine 168
- Endocrinology, Diabetes and Metabolism 166
- Cancer Research 149
- Pharmacology 69
Countries citing papers authored by Ballentine Carter
This map shows the geographic impact of Ballentine Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ballentine Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ballentine Carter more than expected).
Fields of papers citing papers by Ballentine Carter
This network shows the impact of papers produced by Ballentine Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ballentine Carter. The network helps show where Ballentine Carter may publish in the future.
Co-authorship network of co-authors of Ballentine Carter
This figure shows the co-authorship network connecting the top 25 collaborators of Ballentine Carter. A scholar is included among the top collaborators of Ballentine Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ballentine Carter. Ballentine Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 66 | |
| 2 | A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsybreakdown → | 209 |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 170 |
About Ballentine Carter
Ballentine Carter is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine and Urology, having authored 7 papers that have together received 454 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (4 papers) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (166 citations), Cancer Research (149 citations) and Pulmonary and Respiratory Medicine (168 citations). Ballentine Carter has collaborated with scholars based in United States. Frequent co-authors include R. P. Mac, Shalender Bhasin, Glenn R. Cunningham, Atam B. Singh, Alan W. Partin, Johan Skog, Michael Donovan, James M. McKiernan, Phillipp Torkler and Gordon Brown. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.